China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
1.450
+0.010 (0.69%)
Dec 5, 2025, 5:15 PM CET
52.63%
Market Cap 3.57B
Revenue (ttm) 934.24M
Net Income (ttm) 196.19M
Shares Out n/a
EPS (ttm) 0.08
PE Ratio 18.17
Forward PE 15.96
Dividend 0.03 (2.31%)
Ex-Dividend Date Aug 29, 2025
Volume 544
Average Volume 198
Open 1.460
Previous Close 1.440
Day's Range 1.450 - 1.460
52-Week Range 0.805 - 1.650
Beta n/a
RSI 43.80
Earnings Date Nov 17, 2025

About FRA:2M7C

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Sector Healthcare
Founded 1995
Employees 6,141
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.